This National Academies workshop, convened by the National Cancer Policy Forum in collaboration with the Forum on Drug Discovery, Development, and Translation, examined opportunities to improve the care and outcomes for patients with cancer through public-private partnerships for clinical cancer research.
Planning Committee
Roy S. Herbst, Yale University (Co-chair)
Richard L. Schilsky, University of Chicago (Co-chair)
Gideon Blumenthal, Merck
Otis W. Brawley, Johns Hopkins University Center
Chanita Hughes-Halbert, University of Southern California
Samir N. Khleif, Georgetown University Center
Esther Krofah, Milken Institute and FasterCures
Scott M. Lippman, University of California, San Diego
Neal Meropol, Flatiron Health
Edith Perez, Mayo Clinic and Bolt Biotherapeutics
Kristen Rosati, Coppersmith Brockelman PLC
Lawrence Shulman, University of Pennsylvania
Heidi Smith, Novartis Pharmaceuticals
Robert Winn, Virginia Commonwealth University
Speakers and Moderators
Stacey Adam, Foundation for the National Institutes of Health
Jeff Allen, Friends of Cancer Research
Kirsten Bibbins-Domingo, Journal of the American Medical Association
Barbara Bierer, Harvard University
Josh Bilenker, Treeline Biosciences
Chuck Blanke, Oregon Health & Science University
Gideon Blumenthal, Merck
Otis W. Brawley, Johns Hopkins University
Penny Burgoon, National Institutes of Health
John Byrd, University of Cincinnati
Matthew Cooney, Tempus
William L. Dahut, American Cancer Society
Janet Dancey, Canadian Cancer Trials Group
James Doroshow, National Cancer Institute
Gail Eckhardt, University of Texas at Austin
Elizabeth Garrett-Mayer, American Society of Clinical Oncology
Julie Gerberding, Foundation for the National Institutes of Health
Vassilis Golfinopoulos, European Organisation for Research and Treatment
Prashanth Gopalakrishna, Pfizer Inc.
Aida Habtezion, Pfizer Inc.
Roy Herbst, Yale University
Tony Hickson, Cancer Research UK/Cancer Research Horizons
Melissa Johnson, Sarah Cannon Research Institute
Esther Krofah, Milken Institute and FasterCures
Stacie Lindsey, Cholangiocarcinoma Foundation
Erica Mayer, Dana-Farber Cancer Institute
Deven McGraw, Invitae
Neal Meropol, Flatiron Health
Meg Mooney, National Cancer Institute
Michael Morris, Memorial Sloan Kettering Cancer Center
Carolyn Y. Muller, University of New Mexico
Gwen Nichols, Leukemia and Lymphoma Society
Geoffrey Oxnard, Loxo Oncology, Eli Lilly
Richard Pazdur, FDA Oncology Center of Excellence
Edith Perez, Mayo Clinic and Bolt Biotherapeutics
Karen L. Reckamp, Cedars Sinai
Kristen Rosati, Coppersmith Brockelman PLC
Eric Rubin, New England Journal of Medicine
Richard L. Schilsky, University of Chicago
Lawrence Shulman, University of Pennsylvania Abramson Cancer Center
Ellen Sigal, Friends of Cancer Research
Dinah S. Singer, National Cancer Institute
Harpreet Singh, FDA Oncology Center of Excellence
Heidi Smith, Novartis Pharmaceuticals
Craig Tendler, Johnson and Johnson